Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effectiveness of Serum Chromogranin A (CgA) Levels on Diagnostic Relevance, Response After Surgical Resection and Recurrence of Pancreatic Endocrine Tumors (PET)

NCT02759718 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT02759718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02759718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effectiveness of Serum Chromogranin A (CgA) Levels on Diagnostic Relevance, Response After Surgical Resection and Recurrence of Pancreatic Endocrine Tumors (PET)
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2012
Completion date
May 31, 2017
Enrollment
111 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non functioning pancreatic endocrine tumor